| For: | Zheng CW, Yang YM, Yang H. Impact of oxaliplatin and trastuzumab combination therapy on tumor markers and T lymphocyte subsets for advanced gastric cancer. World J Gastrointest Oncol 2024; 16(9): 3905-3912 [PMID: 39350984 DOI: 10.4251/wjgo.v16.i9.3905] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v16/i9/3905.htm |
| Number | Citing Articles |
| 1 |
Taiki Nakashima, Ryu Matsumoto, Kiyonori Tanoue, Chieri Nakayama, Kazuki Sameshima, Yuto Hozaka, Takaaki Arigami, Daisuke Matsushita, Masataka Shimonosono, Yusuke Tsuruda, Ken Sasaki, Yuko Mataki, Takao Ohtsuka. RBBP8 Is a Prognostic Biomarker Associated With Response to Immune Checkpoint Inhibitors in Advanced Gastric Cancer. Journal of Immunotherapy 2025; 48(4) doi: 10.1097/CJI.0000000000000550
|
| 2 |
Hong-Liang Quan, Lin Xia, Yan Hu, Gui-Yuan Wang, Chao Wang. Impact of sintilimab with first-line therapy on tumor marker response in advanced gastric cancer. World Journal of Gastrointestinal Oncology 2026; 18(5): 117085 doi: 10.4251/wjgo.v18.i5.117085
|
| 3 |
Ana Carolina Pires, Pedro Luiz Serrano Uson Junior. Enhancing T-cell response with monoclonal antibodies and chemotherapy in advanced gastric cancer. World Journal of Gastrointestinal Oncology 2025; 17(7): 104806 doi: 10.4251/wjgo.v17.i7.104806
|